In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
about
Chryseomonas luteola identified as the source of serious infections in a Moroccan University HospitalCloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases.Incidence of vaginal Weeksella virosa (formerly group IIf).Evaluation of autoSCAN-W/A and the Vitek GNI+ AutoMicrobic system for identification of non-glucose-fermenting gram-negative bacilli.Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenemActivities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsReappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.Mezlocillin susceptibility tests by the single-disk agar diffusion methodComparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolatesStatistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilliSphingobacterium multivorum: case report and literature review.In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancerFatal case of Weeksella virosa sepsis.Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolatesHuman infections associated with Bordetella bronchiseptica.Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis.Microbiological characteristics of Weeksella virosa (formerly CDC group IIf) isolated from the human genitourinary tract.Critical evaluation of the AutoMicrobic system gram-negative identification card for identification of glucose-nonfermenting gram-negative rodsUnusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysisSize of diffusion pore of Alcaligenes faecalis.Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolatesRole of porins in intrinsic antibiotic resistance of Pseudomonas cepacia.Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.Postoperative infant septicemia caused by Pseudomonas luteola (CDC group Ve-1) and Pseudomonas oryzihabitans (CDC group Ve-2).Septicemia caused by Sphingobacterium multivorum.Bacteremia caused by CDC group Ve-1 in previously healthy patient with granulomatous hepatitis.Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile.Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.Microbiological characteristics of a novel species most closely related to 'Bergeyella cardium' as a pathogen of infectious endocarditis.
P2860
Q24624387-3F4ED7B8-BFD3-4BC4-9044-1CF1D1897669Q30764300-5EE7C54B-74F0-4CF7-8E2E-C36BB6A1FB57Q33838841-B4767F6F-3412-4656-AD09-817D71E83065Q33966017-8CAF8E98-69C2-4A99-BD71-F55CD1DC3DE7Q34431842-D2E18285-EF58-46DD-B7D3-443AFB7138F5Q34734070-B402927F-4452-43C4-ADF4-B321B4E22456Q35123308-E1EB83C2-6A9A-4AF4-8B1A-492C73A46443Q35134821-A242C558-990F-4085-B414-F7AC1B125CD8Q35136615-B84CC1B4-E053-4E93-B8EF-9488D22E9910Q35137076-BD2F68E5-49EE-44CE-BE7A-CCBAEB8D2581Q35139470-55D47B9C-A5D2-4243-B990-6EC35CCDAEA6Q35668944-5C3423DE-9FCE-4ACA-9DFE-D08A0A21A17BQ35713674-E4A17849-7E72-41DC-BA15-7659A38BCE83Q35749296-7B839B12-0696-482A-943C-0C952748F900Q35849346-5AB48A80-79EB-465E-A710-474E199C74F1Q35900420-4FFFCA73-F9AE-4C29-8221-D4F656232FCFQ36414205-9BD13A88-6483-4A1E-B12F-4FC93B22BDADQ36544171-976C03D1-5A00-4C59-9DA5-2029B3E38B64Q36637604-6ED538E6-0719-4E14-AB6F-2C5848AF2629Q37140056-A430947B-14AA-4471-9767-9920F5042767Q37191432-9E606212-2039-47E2-8683-599B5819A13DQ37202067-0CAD08C8-E033-4523-A18C-785A4F4F3201Q37281320-724592FF-8F08-444C-915C-0B216875BCADQ39817831-0B1E7808-0CBC-4C29-91CB-F4372E1C43C2Q39819283-EEA82E61-CAE1-4C83-8C78-1B048FD863FBQ39827526-F65DC62C-D152-49FD-9263-63C5560E5693Q39851752-795BD075-298F-4EBD-928B-4ACDE39C390BQ39856404-249B365D-9415-447B-9641-C4E2DF6A0915Q39856904-4D4F0915-E0A1-4556-BC8A-887E19FE3EACQ40194058-FC884EC4-4C92-404E-A4D0-7B31B809992EQ40207992-B0FB4367-1873-4738-8BEF-38CE76F6EA64Q40209250-C7DFDE6E-D3ED-4812-855B-38AE95566322Q41834831-1C167C3A-D29C-494A-A148-CC8FD7C03094Q42134415-A8B7F728-14C7-4329-A5F6-F5F74AA2110CQ49529441-597427A4-1E9B-4D0B-9878-CA24BABD4DDC
P2860
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
In vitro susceptibilities of n ...... sa to 32 antimicrobial agents.
@en
type
label
In vitro susceptibilities of n ...... sa to 32 antimicrobial agents.
@en
prefLabel
In vitro susceptibilities of n ...... sa to 32 antimicrobial agents.
@en
P356
P1476
In vitro susceptibilities of n ...... osa to 32 antimicrobial agents
@en
P2093
P304
P356
10.1093/CLINIDS/2.6.841
P577
1980-11-01T00:00:00Z